IBDEI04K ; ; 20-FEB-2013
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 20, 2013
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,5747,0)
 ;;=791.0^^55^471^20
 ;;^UTILITY(U,$J,358.3,5747,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5747,1,3,0)
 ;;=3^791.0
 ;;^UTILITY(U,$J,358.3,5747,1,4,0)
 ;;=4^PROTEINURIA
 ;;^UTILITY(U,$J,358.3,5747,2)
 ;;=^99873
 ;;^UTILITY(U,$J,358.3,5748,0)
 ;;=590.80^^55^471^21
 ;;^UTILITY(U,$J,358.3,5748,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5748,1,3,0)
 ;;=3^590.80
 ;;^UTILITY(U,$J,358.3,5748,1,4,0)
 ;;=4^PYELONEPHRITIS NOS
 ;;^UTILITY(U,$J,358.3,5748,2)
 ;;=^101463
 ;;^UTILITY(U,$J,358.3,5749,0)
 ;;=592.0^^55^471^22
 ;;^UTILITY(U,$J,358.3,5749,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5749,1,3,0)
 ;;=3^592.0
 ;;^UTILITY(U,$J,358.3,5749,1,4,0)
 ;;=4^RENAL CALCULI
 ;;^UTILITY(U,$J,358.3,5749,2)
 ;;=^67056
 ;;^UTILITY(U,$J,358.3,5750,0)
 ;;=597.80^^55^471^23
 ;;^UTILITY(U,$J,358.3,5750,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5750,1,3,0)
 ;;=3^597.80
 ;;^UTILITY(U,$J,358.3,5750,1,4,0)
 ;;=4^URETHRITIS NOS
 ;;^UTILITY(U,$J,358.3,5750,2)
 ;;=^124214
 ;;^UTILITY(U,$J,358.3,5751,0)
 ;;=788.30^^55^471^25
 ;;^UTILITY(U,$J,358.3,5751,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5751,1,3,0)
 ;;=3^788.30
 ;;^UTILITY(U,$J,358.3,5751,1,4,0)
 ;;=4^URINARY INCONTINENCE
 ;;^UTILITY(U,$J,358.3,5751,2)
 ;;=^124400
 ;;^UTILITY(U,$J,358.3,5752,0)
 ;;=599.0^^55^471^24
 ;;^UTILITY(U,$J,358.3,5752,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5752,1,3,0)
 ;;=3^599.0
 ;;^UTILITY(U,$J,358.3,5752,1,4,0)
 ;;=4^URIN TRACT INFECTION NOS
 ;;^UTILITY(U,$J,358.3,5752,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,5753,0)
 ;;=585.1^^55^471^2
 ;;^UTILITY(U,$J,358.3,5753,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5753,1,3,0)
 ;;=3^585.1
 ;;^UTILITY(U,$J,358.3,5753,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE I
 ;;^UTILITY(U,$J,358.3,5753,2)
 ;;=^332807
 ;;^UTILITY(U,$J,358.3,5754,0)
 ;;=585.2^^55^471^3
 ;;^UTILITY(U,$J,358.3,5754,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5754,1,3,0)
 ;;=3^585.2
 ;;^UTILITY(U,$J,358.3,5754,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE II
 ;;^UTILITY(U,$J,358.3,5754,2)
 ;;=^332808
 ;;^UTILITY(U,$J,358.3,5755,0)
 ;;=585.3^^55^471^4
 ;;^UTILITY(U,$J,358.3,5755,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5755,1,3,0)
 ;;=3^585.3
 ;;^UTILITY(U,$J,358.3,5755,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE III
 ;;^UTILITY(U,$J,358.3,5755,2)
 ;;=^332809
 ;;^UTILITY(U,$J,358.3,5756,0)
 ;;=585.4^^55^471^5
 ;;^UTILITY(U,$J,358.3,5756,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5756,1,3,0)
 ;;=3^585.4
 ;;^UTILITY(U,$J,358.3,5756,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE IV
 ;;^UTILITY(U,$J,358.3,5756,2)
 ;;=^332810
 ;;^UTILITY(U,$J,358.3,5757,0)
 ;;=585.5^^55^471^6
 ;;^UTILITY(U,$J,358.3,5757,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5757,1,3,0)
 ;;=3^585.5
 ;;^UTILITY(U,$J,358.3,5757,1,4,0)
 ;;=4^CHR KIDNEY DIS STAGE V
 ;;^UTILITY(U,$J,358.3,5757,2)
 ;;=^332811
 ;;^UTILITY(U,$J,358.3,5758,0)
 ;;=585.6^^55^471^10
 ;;^UTILITY(U,$J,358.3,5758,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5758,1,3,0)
 ;;=3^585.6
 ;;^UTILITY(U,$J,358.3,5758,1,4,0)
 ;;=4^ESRD
 ;;^UTILITY(U,$J,358.3,5758,2)
 ;;=^303986
 ;;^UTILITY(U,$J,358.3,5759,0)
 ;;=281.1^^55^472^2
 ;;^UTILITY(U,$J,358.3,5759,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5759,1,3,0)
 ;;=3^281.1
 ;;^UTILITY(U,$J,358.3,5759,1,4,0)
 ;;=4^ANEMIA,B12 DEF
 ;;^UTILITY(U,$J,358.3,5759,2)
 ;;=^267974
 ;;^UTILITY(U,$J,358.3,5760,0)
 ;;=281.2^^55^472^3
 ;;^UTILITY(U,$J,358.3,5760,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5760,1,3,0)
 ;;=3^281.2
 ;;^UTILITY(U,$J,358.3,5760,1,4,0)
 ;;=4^ANEMIA,FOLATE DEF
 ;;^UTILITY(U,$J,358.3,5760,2)
 ;;=^259686
 ;;^UTILITY(U,$J,358.3,5761,0)
 ;;=280.9^^55^472^4
 ;;^UTILITY(U,$J,358.3,5761,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5761,1,3,0)
 ;;=3^280.9
 ;;^UTILITY(U,$J,358.3,5761,1,4,0)
 ;;=4^ANEMIA,IRON DEF
 ;;^UTILITY(U,$J,358.3,5761,2)
 ;;=^276946
 ;;^UTILITY(U,$J,358.3,5762,0)
 ;;=285.8^^55^472^1
 ;;^UTILITY(U,$J,358.3,5762,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5762,1,3,0)
 ;;=3^285.8
 ;;^UTILITY(U,$J,358.3,5762,1,4,0)
 ;;=4^ANEMIA NEC
 ;;^UTILITY(U,$J,358.3,5762,2)
 ;;=^87876
 ;;^UTILITY(U,$J,358.3,5763,0)
 ;;=282.2^^55^472^5
 ;;^UTILITY(U,$J,358.3,5763,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5763,1,3,0)
 ;;=3^282.2
 ;;^UTILITY(U,$J,358.3,5763,1,4,0)
 ;;=4^G6Pd DEFICIENCY
 ;;^UTILITY(U,$J,358.3,5763,2)
 ;;=^7225
 ;;^UTILITY(U,$J,358.3,5764,0)
 ;;=V08.^^55^472^6
 ;;^UTILITY(U,$J,358.3,5764,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5764,1,3,0)
 ;;=3^V08.
 ;;^UTILITY(U,$J,358.3,5764,1,4,0)
 ;;=4^HIV+ (ASYMPTOMATIC)
 ;;^UTILITY(U,$J,358.3,5764,2)
 ;;=^303392
 ;;^UTILITY(U,$J,358.3,5765,0)
 ;;=279.3^^55^472^7
 ;;^UTILITY(U,$J,358.3,5765,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5765,1,3,0)
 ;;=3^279.3
 ;;^UTILITY(U,$J,358.3,5765,1,4,0)
 ;;=4^IMMUNITY DEFICIENCY NOS
 ;;^UTILITY(U,$J,358.3,5765,2)
 ;;=^267969
 ;;^UTILITY(U,$J,358.3,5766,0)
 ;;=785.6^^55^472^8
 ;;^UTILITY(U,$J,358.3,5766,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5766,1,3,0)
 ;;=3^785.6
 ;;^UTILITY(U,$J,358.3,5766,1,4,0)
 ;;=4^LYMPHADENOPATHY
 ;;^UTILITY(U,$J,358.3,5766,2)
 ;;=^72368
 ;;^UTILITY(U,$J,358.3,5767,0)
 ;;=075.^^55^472^9
 ;;^UTILITY(U,$J,358.3,5767,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5767,1,3,0)
 ;;=3^075.
 ;;^UTILITY(U,$J,358.3,5767,1,4,0)
 ;;=4^MONONUCLEOSIS
 ;;^UTILITY(U,$J,358.3,5767,2)
 ;;=^62797
 ;;^UTILITY(U,$J,358.3,5768,0)
 ;;=238.4^^55^472^10
 ;;^UTILITY(U,$J,358.3,5768,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5768,1,3,0)
 ;;=3^238.4
 ;;^UTILITY(U,$J,358.3,5768,1,4,0)
 ;;=4^POLYCYTHEMIA VERA
 ;;^UTILITY(U,$J,358.3,5768,2)
 ;;=^304816
 ;;^UTILITY(U,$J,358.3,5769,0)
 ;;=282.49^^55^472^11
 ;;^UTILITY(U,$J,358.3,5769,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5769,1,3,0)
 ;;=3^282.49
 ;;^UTILITY(U,$J,358.3,5769,1,4,0)
 ;;=4^THALASSEMIA NEC
 ;;^UTILITY(U,$J,358.3,5769,2)
 ;;=^329910
 ;;^UTILITY(U,$J,358.3,5770,0)
 ;;=287.5^^55^472^12
 ;;^UTILITY(U,$J,358.3,5770,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5770,1,3,0)
 ;;=3^287.5
 ;;^UTILITY(U,$J,358.3,5770,1,4,0)
 ;;=4^THROMBOCYTOPENIA NOS
 ;;^UTILITY(U,$J,358.3,5770,2)
 ;;=^118988
 ;;^UTILITY(U,$J,358.3,5771,0)
 ;;=289.9^^55^472^13
 ;;^UTILITY(U,$J,358.3,5771,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5771,1,3,0)
 ;;=3^289.9
 ;;^UTILITY(U,$J,358.3,5771,1,4,0)
 ;;=4^THROMBOCYTOSIS
 ;;^UTILITY(U,$J,358.3,5771,2)
 ;;=^55344
 ;;^UTILITY(U,$J,358.3,5772,0)
 ;;=401.9^^55^473^1
 ;;^UTILITY(U,$J,358.3,5772,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5772,1,3,0)
 ;;=3^401.9
 ;;^UTILITY(U,$J,358.3,5772,1,4,0)
 ;;=4^HYPERTENSION NOS
 ;;^UTILITY(U,$J,358.3,5772,2)
 ;;=^186630
 ;;^UTILITY(U,$J,358.3,5773,0)
 ;;=401.1^^55^473^3
 ;;^UTILITY(U,$J,358.3,5773,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5773,1,3,0)
 ;;=3^401.1
 ;;^UTILITY(U,$J,358.3,5773,1,4,0)
 ;;=4^HYPERTENSION,BENIGN
 ;;^UTILITY(U,$J,358.3,5773,2)
 ;;=^269591
 ;;^UTILITY(U,$J,358.3,5774,0)
 ;;=401.0^^55^473^2
 ;;^UTILITY(U,$J,358.3,5774,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5774,1,3,0)
 ;;=3^401.0
 ;;^UTILITY(U,$J,358.3,5774,1,4,0)
 ;;=4^HYPERTENSION,ACCELERATED
 ;;^UTILITY(U,$J,358.3,5774,2)
 ;;=^73505
 ;;^UTILITY(U,$J,358.3,5775,0)
 ;;=227.0^^55^474^1
 ;;^UTILITY(U,$J,358.3,5775,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5775,1,3,0)
 ;;=3^227.0
 ;;^UTILITY(U,$J,358.3,5775,1,4,0)
 ;;=4^ADRENAL NEOPLASM,BENIGN
 ;;^UTILITY(U,$J,358.3,5775,2)
 ;;=^267688
 ;;^UTILITY(U,$J,358.3,5776,0)
 ;;=194.0^^55^474^2
 ;;^UTILITY(U,$J,358.3,5776,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5776,1,3,0)
 ;;=3^194.0
 ;;^UTILITY(U,$J,358.3,5776,1,4,0)
 ;;=4^ADRENAL NEOPLASM,MALIGNANT
 ;;^UTILITY(U,$J,358.3,5776,2)
 ;;=^267298
 ;;^UTILITY(U,$J,358.3,5777,0)
 ;;=255.10^^55^474^3
 ;;^UTILITY(U,$J,358.3,5777,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5777,1,3,0)
 ;;=3^255.10
 ;;^UTILITY(U,$J,358.3,5777,1,4,0)
 ;;=4^ALDOSTERONISM
 ;;^UTILITY(U,$J,358.3,5777,2)
 ;;=^330019
 ;;^UTILITY(U,$J,358.3,5778,0)
 ;;=255.0^^55^474^4
 ;;^UTILITY(U,$J,358.3,5778,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5778,1,3,0)
 ;;=3^255.0
 ;;^UTILITY(U,$J,358.3,5778,1,4,0)
 ;;=4^CUSHING'S SYNDROME
 ;;^UTILITY(U,$J,358.3,5778,2)
 ;;=^29802
 ;;^UTILITY(U,$J,358.3,5779,0)
 ;;=403.90^^55^474^6
 ;;^UTILITY(U,$J,358.3,5779,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5779,1,3,0)
 ;;=3^403.90
 ;;^UTILITY(U,$J,358.3,5779,1,4,0)
 ;;=4^HTN RENAL w/o RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,5779,2)
 ;;=^334272
 ;;^UTILITY(U,$J,358.3,5780,0)
 ;;=403.91^^55^474^5
 ;;^UTILITY(U,$J,358.3,5780,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5780,1,3,0)
 ;;=3^403.91
 ;;^UTILITY(U,$J,358.3,5780,1,4,0)
 ;;=4^HTN RENAL w/ RENAL FAILURE NOS
 ;;^UTILITY(U,$J,358.3,5780,2)
 ;;=^334242
 ;;^UTILITY(U,$J,358.3,5781,0)
 ;;=405.91^^55^474^7
 ;;^UTILITY(U,$J,358.3,5781,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5781,1,3,0)
 ;;=3^405.91
 ;;^UTILITY(U,$J,358.3,5781,1,4,0)
 ;;=4^HTN RENOVASCULAR NOS
 ;;^UTILITY(U,$J,358.3,5781,2)
 ;;=^269634
 ;;^UTILITY(U,$J,358.3,5782,0)
 ;;=403.00^^55^474^9
 ;;^UTILITY(U,$J,358.3,5782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5782,1,3,0)
 ;;=3^403.00
 ;;^UTILITY(U,$J,358.3,5782,1,4,0)
 ;;=4^MAL HTN RENAL w/o RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,5782,2)
 ;;=^334270
 ;;^UTILITY(U,$J,358.3,5783,0)
 ;;=403.01^^55^474^8
 ;;^UTILITY(U,$J,358.3,5783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5783,1,3,0)
 ;;=3^403.01
 ;;^UTILITY(U,$J,358.3,5783,1,4,0)
 ;;=4^MAL HTN RENAL w/ RENAL FAILURE
 ;;^UTILITY(U,$J,358.3,5783,2)
 ;;=^334240
 ;;^UTILITY(U,$J,358.3,5784,0)
 ;;=405.01^^55^474^10
 ;;^UTILITY(U,$J,358.3,5784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5784,1,3,0)
 ;;=3^405.01
 ;;^UTILITY(U,$J,358.3,5784,1,4,0)
 ;;=4^MAL HTN RENOVASCULAR
 ;;^UTILITY(U,$J,358.3,5784,2)
 ;;=^269628
 ;;^UTILITY(U,$J,358.3,5785,0)
 ;;=404.91^^55^475^1
 ;;^UTILITY(U,$J,358.3,5785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,5785,1,3,0)
 ;;=3^404.91
 ;;^UTILITY(U,$J,358.3,5785,1,4,0)
 ;;=4^HTN HRT/REN w/ CHF,NOS
